Resistance of CAR-T Immunotherapy For Hematological Cancers

Explore the advancements in CAR-T immunotherapy for relapsed/refractory B cell lymphomas and leukemia in an exclusive webcast featuring Dr. Marco Ruella, a distinguished expert in cellular immunotherapies.

Dr. Ruella’s presentation will showcase innovative research focusing on enhancing CAR-T therapy by uncovering tumor evasion mechanisms and addressing challenges in CAR-T cell dysfunction and the suppressive tumor microenvironment. Gain insights into cutting-edge techniques like scRNA sequencing and spatial transcriptomics used to analyze resistance mechanisms and develop novel CAR-T products. Don’t miss out on learning about resistance mechanisms, advanced research techniques, and key elements in enhancing CAR-T therapy.

Watch this webinar to learn about:

• Mechanisms of resistance to CAR-T cells
• Next generation techniques to study and develop novel CAR-T products
• Caveats on improving manual perturbation issues, highlighting rare sample management and the value of fit-for-purpose screening